Oxidronic acid API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Oxidronic acid API 15468-10-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Oxidronic acid. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Oxidronic acid
- Synonyms:
- (Hydroxymethylene)diphosphonic acid , Acido oxidronico , Acidum oxidronicum , HMD-P , HMDP , Hydroxymethanediphosphonic acid , Oxidronate , Oxidronic acid
- Cas Number:
- 15468-10-7
- DrugBank number:
- DB14159
- Unique Ingredient Identifier:
- 71MR4V32TI
General Description:
Oxidronic acid is a chemical compound identified by the CAS number 15468-10-7. It is known for its distinct pharmacological properties and applications.
Indications:
This drug is primarily indicated for: Oxidronic acid is a diagnostic skeletal imaging agent used to demonstrate areas of altered osteogenesis in adult and pediatric patients. Its use in specific medical scenarios underscores its importance in the therapeutic landscape.
Categories:
Oxidronic acid is categorized under the following therapeutic classes: Organophosphonates, Organophosphorus Compounds. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Oxidronic acid is a type of Diagnostic agents
Diagnostic agents are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) used in the field of medical diagnostics. These agents play a vital role in diagnosing various diseases and conditions by aiding in the visualization and identification of specific biomarkers or structures within the body.
Diagnostic agents encompass a wide range of substances, including contrast agents, radiopharmaceuticals, and imaging agents. Contrast agents are commonly used in medical imaging techniques such as X-rays, magnetic resonance imaging (MRI), and computed tomography (CT) scans. They enhance the visibility of certain tissues or organs, allowing healthcare professionals to detect abnormalities more accurately.
Radiopharmaceuticals are another type of diagnostic agent that combines a radioactive component with a pharmaceutical compound. These agents emit radiation that can be detected by specialized imaging equipment, enabling the visualization of metabolic processes and the identification of abnormal cellular activity.
Imaging agents are designed to target specific molecular structures or biomarkers within the body. They can be used to detect and visualize specific proteins, enzymes, or receptors associated with certain diseases or conditions. By targeting these specific biomarkers, imaging agents provide valuable information about the presence, location, and extent of a disease, aiding in diagnosis and treatment planning.
Overall, diagnostic agents are essential tools in modern medicine, facilitating accurate and timely diagnoses. These pharmaceutical APIs enable healthcare professionals to identify and monitor diseases at an early stage, leading to better patient outcomes and improved treatment strategies.
